{{Rsnum
|rsid=1092913
|Chromosome=5
|position=10467590
|Orientation=plus
|GMAF=0.3375
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;G)
|geno3=(G;G)
|Gene=ROPN1L
|Gene_s=ROPN1L
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;G)
| geno3=(G;G)
| CEU | 0.9 | 18.6 | 80.5
| HCB | 51.5 | 39.0 | 9.6
| JPT | 38.1 | 54.0 | 8.0
| YRI | 8.9 | 32.9 | 58.2
| ASW | 9.1 | 40.0 | 50.9
| CHB | 51.5 | 39.0 | 9.6
| CHD | 46.8 | 45.9 | 7.3
| GIH | 10.9 | 44.6 | 44.6
| LWK | 8.2 | 46.4 | 45.5
| MEX | 15.8 | 59.6 | 24.6
| MKK | 10.3 | 39.1 | 50.6
| TSI | 0.0 | 15.7 | 84.3
| HapMapRevision=28
}}{{PMID Auto GWAS
|PMID=21424380
|Trait=None
|Title=Potential novel candidate polymorphisms identified in genome-wide association study for breast cancer susceptibility.
|RiskAllele=T
|Pval=0.000002
|OR=1.4500
|ORtxt=[1.24-1.69]
|OA=1
}}

{{PMID Auto
|PMID=22452962
|Title=A genome-wide association study identifies a breast cancer risk variant in ERBB4 at 2q34: results from the Seoul Breast Cancer Study
|OA=1
}}

{{on chip | Affy GenomeWide 6}}